Donanemab
ATC N06DX05 · 10 markets · 11 records
AU 2 records · 2 strengths
- 17.5 mg/mLinjectionKISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 strengths
- 17.5 mginjectionKisunla
GB 1 records · 1 strengths
- 350 mg/20 mLinjectionKisunla 350mg/20ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 17.5 mgliquidKisunla
SG 1 records · 1 strengths
- 350 mg/20 mLinjectionLormalzi Concentrate for Solution for Infusion 350mg/20mL
CN 1 records · 1 strengths
- 350 mg/20 mLinjection记能达多奈单抗
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 strengths
- 350 mg/20 mLinjectionKisunla欣智樂注射劑 350毫克/20毫升
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.